150 related articles for article (PubMed ID: 2476406)
21. Comparative trial of mexiletine and lignocaine in the treatment of ventricular arrhythmias.
Sathyamurthy I; Krishnaswami S; Padmakumar P; Mao R
Indian Heart J; 1985; 37(6):361-5. PubMed ID: 3915491
[No Abstract] [Full Text] [Related]
22. Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes.
Mehta J; Conti CR
Am J Cardiol; 1982 Feb; 49(2):455-60. PubMed ID: 6174042
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of rhythm disorders of ventricular origin with KO 1173 (Mexiletin) (author's transl)].
Esser H; Kikis D
Med Klin; 1977 Sep; 72(35):1386-91. PubMed ID: 71652
[TBL] [Abstract][Full Text] [Related]
25. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
Mondillo S; Faglia S; D'Aprile N; Mangiacotti L; Campolo MA; Agricola E; Palazzuoli V
Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496
[TBL] [Abstract][Full Text] [Related]
26. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
[TBL] [Abstract][Full Text] [Related]
27. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia.
Kubac G; Klinke WP; Grace M
Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834
[TBL] [Abstract][Full Text] [Related]
28. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Klempt HW; Nayebagha A; Fabry E
Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
[TBL] [Abstract][Full Text] [Related]
29. [Comparative evaluation of biological availability and anti-arrhythmia effectiveness of Mexicard (mexiletine Polfa)].
Sadowski Z; Paczkowski D; Markiewicz M; Nartowicz E; Koliński P; Filipek M
Kardiol Pol; 1989; 32(5):266-72. PubMed ID: 2483958
[TBL] [Abstract][Full Text] [Related]
30. Mexiletine in the treatment of ventricular arrhythmias.
Henrard L; Carlier J
Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of ventricular arrhythmias with mexiletine].
Trenckmann H; Neugebauer A; Krosse B
Z Gesamte Inn Med; 1982 May; 37(9):259-62. PubMed ID: 7048773
[TBL] [Abstract][Full Text] [Related]
32. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
Mastropasqua F; Totaro P; Massari F; Pitzalis MV; Rizzon P
Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
[TBL] [Abstract][Full Text] [Related]
33. [Anti-arrhythmic effects of mexiletine].
Ledain L; Page A; Favreau L; Besse P
Arch Mal Coeur Vaiss; 1982 May; 75(5):605-12. PubMed ID: 6180692
[TBL] [Abstract][Full Text] [Related]
34. [Comparative evaluation of mexiletine and propafenone by dynamic electrocardiography].
Marzegalli M; Bernasconi M; Brambilla G; Micheletti T; Potenza S; Regalia F; Barbaresco L; Bossi M
G Ital Cardiol; 1984 May; 14(5):352-6. PubMed ID: 6468816
[TBL] [Abstract][Full Text] [Related]
35. [Therapy of ventricular arrhythmias with propafenone].
Petri H; Kafka W; Rudolph W
Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
[TBL] [Abstract][Full Text] [Related]
36. [Mexiletine therapy of ventricular extrasystoles in the acute phase of myocardial infarction].
Juillard A; Bouajina A; Barrillon A; Gay J; Gerbaux A
Ann Cardiol Angeiol (Paris); 1984; 33(2):117-20. PubMed ID: 6201121
[TBL] [Abstract][Full Text] [Related]
37. [Clinical study evaluated by Holter monitoring and by mexiletine serum levels in ventricular arrhythmias].
Meoli P; Sanna GP; Rovelli F
G Ital Cardiol; 1982; 12(2):115-21. PubMed ID: 6757036
[TBL] [Abstract][Full Text] [Related]
38. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic use of mexiletine in the elderly with acute myocardial infarction.
Datta-Chaudhari ML; O'Brien TD
J Assoc Physicians India; 1990 Feb; 38(2):144-7. PubMed ID: 2199424
[TBL] [Abstract][Full Text] [Related]
40. [Clinical electrophysiological evaluation of mexiletine].
Molina L; Colín L; Micheletti T; Blank S; Camacho J
Arch Inst Cardiol Mex; 1986; 56(3):219-23. PubMed ID: 2944491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
